Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Pharmacogenetic testing in the...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Pharmacogenetic testing in the treatment of type 2 diabetes with sulfonylurea drugs

Pharmacogenetic testing in the treatment of type 2 diabetes with sulfonylurea drugs

The article analyses scientific literature on the use of pharmacogenetic testing to optimize sulfonylurea treatment of patients with type 2 diabetes. It describes characteristics of modern sulfonylurea drugs used in the treatment of type 2 diabetes, including their mode of action, and the frequency...

Full description

Bibliographic Details
Main Authors: G. I. Gorodetskaya, V. G. Kukes, S. A. Belkov, R. E. Kazakov, S. Yu. Serebrova, O. V. Muslimova, T. A. Rodina, A. A. Aleksandrov
Format: Article
Language:Russian
Published: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2018-02-01
Series:Регуляторные исследования и экспертиза лекарственных средств
Subjects:
сахарный диабет 2 типа
гипогликемия
препараты сульфонилмочевины
полиморфизмы генов
лозартановый тест
type 2 diabetes
hypoglycaemia
sulfonylureas
gene polymorphisms
losartan test
Online Access:https://www.vedomostincesmp.ru/jour/article/view/146
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.vedomostincesmp.ru/jour/article/view/146

Similar Items

  • Vzaimosvyaz' mezhdu avtonomnoy nevropatiey i bessimptomnymi gipoglikemiyami u patsientov s sakharnym diabetom 1 tipa
    by: O V Svetlova, et al.
    Published: (2008-12-01)
  • Vliyanie glimepirida (Amarila) na sostoyanie lipidnogo obmena, perekisnoe okislenie lipidov i insulinrezistentnost'
    by: Mikhail Ivanovich Balabolkin, et al.
    Published: (2003-09-01)
  • O lechenii sakharnogo diabeta 2 tipa glimepiridom
    by: Ashot Musaelovich Mkrtumyan
    Published: (2000-12-01)
  • Beta-adrenoblokatory pri serdechnoy nedostatochnosti u bol'nykh sakharnym diabetom 2 tipa: karvedilol i risk gipoglikemiy
    by: Andrey Alexeevich Aleksandrov, et al.
    Published: (2008-03-01)
  • Osnovnye printsipy terapii sakharnogo diabeta 2 tipa
    by: Ivan Ivanovich Dedov, et al.
    Published: (1999-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs